Pharming (PHAR) EBITDA (2020 - 2026)
Pharming (PHAR) posted EBITDA of -$4.9 million for Q1 2026, down 79209777.42% on a QoQ basis from $6.2 in Q4 2025, and down 69718809.71% year-over-year from N/an in Q1 2025.
Pharming (PHAR) EBITDA (2020 - 2026) Analysis & Trends
Pharming's EBITDA history runs 7 years deep, the most recent figure standing at -$4.9 million for Q1 2026.
- Quarterly EBITDA fell 69718809.71% year-over-year to -$4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.9 million (up 145.46% YoY) and the FY2025 annual result came in at $25.8 million, up 399.76% from the prior year.
- EBITDA was -$4.9 million for Q1 2026 at Pharming, down from $6.2 in the prior quarter.
- Across five years, EBITDA topped out at $5300.0 billion in Q2 2023 and bottomed at -$19.4 million in Q2 2024.
- A 5-year average of $311.8 billion and a median of $6.2 in 2025 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2023 — EBITDA surged 29775180.9% — and 2024, when it plunged 132630669.23%.
- Pharming's EBITDA stood at $28.4 million in 2022, then plunged by 100.0% to -$6.5 in 2023, then plunged by 132630669.23% to -$8.6 million in 2024, then soared by 100.0% to $6.2 in 2025, then slumped by 79209777.42% to -$4.9 million in 2026.
- Business Quant data shows PHAR's EBITDA at -$4.9 million in Q1 2026, $6.2 in Q4 2025, and $15.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | -4.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.91 Mn |
| Dec 31, 2025 | 6.20 |
| Sep 30, 2025 | 15.80 Mn |
| Jun 30, 2025 | 3.81 |
| Mar 31, 2025 | -7.04 |
| Dec 31, 2024 | -8.62 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | -19.43 Mn |
| Mar 31, 2024 | -16.31 |
| Dec 31, 2023 | -6.50 |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 5,300.00 Bn |
| Mar 31, 2023 | -13.66 Mn |
| Dec 31, 2022 | 28.40 Mn |
| Sep 30, 2022 | 7.80 Mn |
| Jun 30, 2022 | 17.80 Mn |
| Mar 31, 2022 | 2.80 Mn |
| Dec 31, 2021 | -14.63 Mn |
| Sep 30, 2021 | -1.68 Mn |
| Jun 30, 2021 | 10.85 Mn |